Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- NHS England · Body governed by public law
- Suppliers
- University College London Hospitals NHS Foundation Trust, The Newcastle upon Tyne Hospitals NHS Foundation Trust, The Christie NHS Foundation Trust, The Clatterbridge Cancer Centre NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust, Barts Health NHS Trust, The Royal Marsden NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Oxford University Hospitals NHS FT, University Hospitals Southampton, University Hospitals Bristol and Weston NHS Foundation Trust, University Hospitals of Leicester NHS Trust
- Value
- £142,512,000 across 12 lots
- Procedure
- Open procedure
- Sector
- Health & social care · Health services (CPV 85100000)
- Region
- London
- Official notice
- 003869-2026 on Find a Tender
- Timeline
-
- Contract date16 Dec 2025
- Published16 Jan 2026Published 31 days after the contract date
Description
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), invited suitably qualified and experienced providers to respond to a Competitive Process for the provision of Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults). <br/><br/>Lifileucel is a first in class autologous tumour infiltrating lymphocyte (TIL) cell therapy. This infusion is followed by a short course of interleukin-2 (IL-2). IL-2 is a potent drug and has the potential to cause significant side effects. As such, it is recommended that patients receive treatment at a trust with immediate access to an Intensive Therapy<br/>Unit (ITU).<br/><br/>Lifileucel is being assessed via NICE’s technology appraisal programme for previously treated unresectable or metastatic melanoma in adults, with an expected final guidance publication date in 2026 in line with NICE guidance: https://www.nice.org.uk/guidance/indevelopment/gid-ta10752<br/><br…
Lots in this award
| Lot | Supplier | Value |
|---|---|---|
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | University College London Hospitals NHS Foundation Trust | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | The Newcastle upon Tyne Hospitals NHS Foundation Trust | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | The Christie NHS Foundation Trust | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | The Clatterbridge Cancer Centre NHS Foundation Trust | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | Guy's and St Thomas' NHS Foundation Trust | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | Barts Health NHS Trust | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | The Royal Marsden NHS Foundation Trust | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | Cambridge University Hospitals NHS Foundation Trust | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | Oxford University Hospitals NHS FT | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | University Hospitals Southampton | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | University Hospitals Bristol and Weston NHS Foundation Trust | £11.9m |
| Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults) | University Hospitals of Leicester NHS Trust | £11.9m |
About the suppliers
University College London Hospitals NHS Foundation Trust: every public contract they have won.
Guy's and St Thomas' NHS Foundation Trust: every public contract they have won.
Barts Health NHS Trust: every public contract they have won.
The Royal Marsden NHS Foundation Trust: every public contract they have won.
Cambridge University Hospitals NHS Foundation Trust: every public contract they have won.
Oxford University Hospitals NHS FT: every public contract they have won.
University Hospitals Southampton: every public contract they have won.
University Hospitals Bristol and Weston NHS Foundation Trust: every public contract they have won.
University Hospitals of Leicester NHS Trust: every public contract they have won.
The Newcastle upon Tyne Hospitals NHS Foundation Trust: every public contract they have won, plus their Companies House record (company 00130126).
The Christie NHS Foundation Trust: every public contract they have won.
The Clatterbridge Cancer Centre NHS Foundation Trust: every public contract they have won.